VivoSim Labs (VIVS) Change in Account Payables (2011 - 2026)
VivoSim Labs (VIVS) posted Change in Account Payables of -$400000.0 for Q2 2026, down 214.29% on a QoQ basis from $350000.0 in Q1 2026, and up 58.81% year-over-year from -$251880.7 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Change in Account Payables (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Change in Account Payables for 16 years, with the latest figure at -$400000.0 in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 58.81% year-over-year to -$400000.0 in Q2 2026; TTM through Jun 2026 was -$52000.0, a 88.34% increase from a year earlier, with the FY2026 full-year figure at -$623000.0, down 161.26% from the prior year.
- Change in Account Payables was -$400000.0 for Q2 2026 at VivoSim Labs, down from $350000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $714000.0 in Q1 2025, with the low at -$971000.0 in Q2 2025.
- Average Change in Account Payables over 5 years is -$2666.7, with a median of $30500.0 recorded in 2023.
- The largest YoY upside for Change in Account Payables was 1319.44% in 2024 against a maximum downside of 1220.75% in 2024.
- Over 5 years, Change in Account Payables stood at -$199000.0 in 2022, then soared by 118.09% to $36000.0 in 2023, then soared by 1319.44% to $511000.0 in 2024, then plunged by 82.19% to $91000.0 in 2025, then slumped by 539.56% to -$400000.0 in 2026.
- The last three Change in Account Payables figures came in at -$400000.0 (Q2 2026), $350000.0 (Q1 2026), and $91000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -129,000.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 821,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -16.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -1.43 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 872,116.56 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -400,000.00 |
| Mar 31, 2026 | 350,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Mar 31, 2025 | 714,000.00 |
| Dec 31, 2024 | 511,000.00 |
| Sep 30, 2024 | -700,000.00 |
| Jun 30, 2024 | 492,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | -53,000.00 |
| Jun 30, 2023 | 157,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -199,000.00 |
| Sep 30, 2022 | 311,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | -190,000.00 |
| Dec 31, 2021 | -353,000.00 |
| Sep 30, 2021 | 381,000.00 |